Sylvia Ramos

Sylvia Ramos

About

Detail

System Clinical Trials Business Management - City of Hope National Cancer Center
Duarte, California, United States

Timeline


work
Job
school
Education
folder
Project

Résumé


Jobs verified_user 0% verified
  • City of Hope
    OnCore Content Specialist
    City of Hope
    Nov 2020 - Current (5 years 11 months)
  • University of Southern California Cardiothoracic Surgery
    Research Coordinator II
    University of Southern California Cardiothoracic Surgery
    Oct 2014 - Nov 2020 (6 years 2 months)
    My responsibilities include the day-to-day conduct of clinical trials and ensure that research is conducted in compliance with the study protocol as well as federal, state and institutional guidelines and regulations.

    I manage protocol related research procedures, study visits, and follow-up care. Screen, recruit and enroll research participants. Comply with correct informed consent and HIPAA procedures. Maintain study source documents. Report adverse events. Understand good clinical practice (GCP) and regulatory compliance. Educate subjects and family on protocol, study intervention. Manage essential regulatory documents. Complete case report forms (paper & electronic data capture) and address queries. Submit documents to re
  • University of Southern California Dept of Ophthalmology
    Project Specialist
    University of Southern California Dept of Ophthalmology
    Jan 2004 - Jan 2014 (10 years 1 month)
    Research coordinator for several clinical trials as well as primary examiner. Responsible to conduct the studies according to FDA regulations and guidelines, ensuring the safety and welfare of the study participants. Skills in ophthalmology include: ETDRS Manifest refraction-trial frame, JCC, manual, auto, retinoscopy, contact lens over refraction, lensometry, Visual Acuity testing, EVA, Contrast Sensitivity, Anterior segment OCT Imaging, immersion contact, and non contact A-scan, Visual field-Humphrey and Goldmann perimeters, electrophysiology testing, pupil size and reactivity, motility, pachymetry, keratometry, topography, Schirmer, TBUT, sensitivity, IOP by applanation, tonopen, tactile, and slitlamp exam.
  • D
    Ophthalmic Technician
    Doheny Eye Institute
    Feb 2000 - Sep 2004 (4 years 8 months)
  • P
    Ophthalmic Technician
    Pacific EyeNet
    Feb 1986 - Jan 1999 (13 years)
Education verified_user 0% verified
  • Pasadena City College
    Pasadena City College
    Pasadena City College
  • Arizona State University
    Bachelor of Science - BS, Healthcare Compliance and Regulations
    Arizona State University
    Jan 2019 - Jan 2022 (3 years 1 month)
Projects (professional or personal) verified_user 0% verified
  • T
    Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at L
    Jul 2016 - Current (10 years 3 months)
    The study objective is to demonstrate that the safety and effectiveness of the Medtronic TAVR system as measured by rates of all-cause mortality or disabling stroke at two years is noninferior to SAVR in the treatment of severe aortic stenosis in subjects who have a low predicted risk of operative mortality for SAVR.
  • S
    St. Jude Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
    Aug 2015 - Current (11 years 2 months)
    The PORTICO clinical trial is a prospective, multi-center, randomized, controlled clinical study, designed to evaluate the safety and effectiveness of the SJM Portico Transcatheter Heart Valve and Delivery Systems (Portico) via transfemoral and alternative delivery methods.
  • C
    Corneal and Anterior Segment Optical Coherence Tomography - OptoVue
    The objective of the study is to further develop clinical applications for the high speed corneal and anterior segment optical coherence tomography (CAS-OCT) systems developed by Optovue, Inc. (Fremont, CA, USA). The systems are currently designated ACVue and RTVue-CAM (adapted for anterior segment).
  • C
    Corneal and Anterior Segment Optical Coherence Tomography for Contact Lens Design
    The study involves using corneal optical coherence tomography (OCT) to obtain a better understanding of the anatomy of the eye for contact lens design and to assess the quality of contact lens fit. Particularly in characterizing the difference between Asian and Caucasian eyes
  • C
    CHRONIC RETINAL STIMULATION SYSTEM TO PROVIDE ELECTRICAL STIMULATION OF THE RETINA TO ELICIT VISUAL PERCEPTS IN BLIND SU
    The objective of this study is to evaluate the safety and efficacy of the retinal electrode by evaluating the data after chronic implantation
  • F
    Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa
    The objective of this study is to evaluate the safety and efficacy of the retinal stimulation system by evaluating the data after chronic implantation.
  • A
    A Multicenter, Double-blind, Randomized, Placebo-controlled Study of Weight-Reduction and/or Low Sodium Diet plus Acetaz
    Idiopathic intracranial hypertension (IIH), also called pseudotumor cerebri, is a disorder of elevated intracranial pressure of unknown cause [Corbett, et al., 1982; Wall, et al., 1991]. Its incidence is 22.5 new cases each year per 100,000 overweight women of childbearing age, and is rising [Garrett, et al., 2004] in parallel with the obesity epidemic. It affects about 100,000 Americans. Most patients suffer debilitating headaches. Because of pressure on the optic nerve (papilledema), 86% have some degree of permanent visual loss and 10% develop severe visual loss [Wall, et al., 1991]. Interventions to prevent loss of sight, all with unproven efficacy, include diet, diuretics such as acetazolamide, repeated spinal taps, optic nerve sheath
  • G
    Guiding the Treatment of Anterior Eye Diseases with Optical Coherence Tomography
    Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography (OCT IOL)
    The long-term goal of this project is to utilize newly available very high-speed optical coherence tomography (OCT) technology to guide surgical treatments of corneal diseases. OCT is well known for its exquisite resolution, but until recently it has not had sufficient speed to capture the shape of the cornea because of eye motion during OCT scanning. The development of Fourier-domain (FD) OCT technology has made the requisite speed possible.

    The objective of this project is to develop methods for imaging the cornea with an FD-OCT system that will precisely measure corneal shape and use this information to guide
  • D
    Data Collection Study of the Nidek Optical Coherence Tomography RS-3000 for 3D Measurements of the Eye
    The purpose of this clinical study is to collect and evaluate the data from eye scans using an investigational three-dimensional eye imaging photography device called the Nidek Optical Coherence Tomography (OCT) RS-3000. OCT stands for Optical Coherence Tomography, a technique that uses invisible wavelengths of light to make detailed images of the tissues at the back of the eye. These images provide information that physicians may use to help diagnose eye conditions and/or to monitor changes in the eye during treatment.
  • A
    Argus® II Retinal Stimulation System Feasibility Protocol
    The objective of this feasibility study is to evaluate the safety and utility of the Argus II Retinal Stimulation System in providing visual function to blind subjects with severe to profound retinitis pigmentosa.
  • A
    Advanced Imaging for Glaucoma Study (AIGS)
    Project Manager Coordinating Center and Chairman's Office. The purpose of the study is to predict the development of glaucomatous visual field (VF) abnormality in glaucoma suspects and pre-perimetric glaucoma patients based on anatomic abnormalities detected by advanced imaging. Predict the development of glaucomatous VF abnormality in glaucoma suspects and pre-perimetric glaucoma patients based on anatomic changes detected between successive advanced imaging tests. Determine the sensitivity and specificity of glaucoma diagnosis based on advanced imaging tests.
  • R
    Retrospective review of corneal and anterior segment surgical and pathological cases on the Visante Optical Coherence To
  • N
    Neuroprotection in Patients Undergoing Aortic Valve Replacement
    To evaluate the efficacy and safety of embolic protection devices to reduce ischemic brain injury in patients undergoing surgical aortic valve replacement (AVR).
  • W
    WATS3D (Wide Area Transepithelial Sample Biopsy with 3-Dimensional Computer-Assisted Analysis) and Biopsy Forceps for De
    The objective of this study is to collect data from patients undergoing esophagogastroduodenoscopy (EGD) with a combination of targeted forceps biopsy, WATS3D biopsy, and Seattle protocol random forceps biopsy. Long term follow up to refine our current knowledge regarding the true progression rate from Barrett’s esophagus to low grade dysplasia and form low grade dysplasia to high grade dysplasia and esophageal cancer.
  • T
    Topcon OCT Reference Database
    To collect OCT measurement data on normal healthy eyes in order to determine the reference limits for Topcon 3D OCT-1 Maestro and for Topcon 3D OCT-2000.
  • M
    Medtronic CoreValve® U.S. Expanded Use Study
    The primary objective of the study is to evaluate the safety and effectiveness of the Medtronic CoreValve® System (MCS) in a subset of subjects excluded from the U.S. Extreme Risk Pivotal Trial population due to one or more additional co-morbidities, as measured by a composite of all-cause death or major stroke at 12 months, in the treatment of symptomatic severe aortic stenosis in subjects necessitating aortic valve replacement. Subjects enrolled in this study have a predicted operative mortality or serious, irreversible morbidity risk of ≥50% at 30 days associated with surgical aortic valve replacement.
  • R
    Repository for Inherited Eye Diseases
    This study will collect blood and DNA samples from patients with inherited eye diseases to be used in research to identify genetic factors responsible for these conditions. In recent years, nearly 500 genes that contribute to inherited eye diseases have been identified. Disease-causing mutations are associated with many eye diseases, including glaucoma, cataracts, strabismus, corneal dystrophies and a number of forms of retinal degenerations. As a result, gene-based therapies are being pursued to treat eye genetic diseases that were once considered untreatable.

    The National Ophthalmic Genotyping Network (eyeGENE ) is creating a national tissue repository to further advance genetic research on inherited eye disease, while at the s
  • T
    Tear Collection and Analysis in Patient with Dry Eyes and Sjögren’s Syndrome
    The objective of this study is to explore the possibility of using biomarkers from tear samples as a predictive marker of disease. .
  • M
    Medtronic CoreValve Evolut R U.S. Clinical Study
    The study objectives are to assess the safety and efficacy of the CoreValve Evolut R transcatheter aortic valve replacement (TAVR) system in patients with severe symptomatic aortic stenosis are considered at high or extreme risk for surgical aortic valve replacement.
  • R
    Rate Control versus Rhythm Control for Post-Operative Atrial Fibrillation
    The purpose of this study is to compare the therapeutic strategies of rate control versus rhythm control in cardiac surgery patients who develop in-hospital postoperative atrial fibrillation or atrial flutter (AF). In patients who develop AF during hospitalization after cardiac surgery, the hypothesis is that a strategy of rhythm control will reduce days in hospital within 60 days of the occurrence of AF compared to a strategy of rate control.
  • N
    NinePoint High Resolution Optical Imaging of Esophageal Tissue Using the Nvision VLE Imaging System Registry
    This is a prospective, multi-site registry with longitudinal follow up for patients undergoing esophagogastroduodenoscopy (EGD) or endoscopy. The primary objective is to provide a collection of patient NvisionVLE™ procedural data for participating physicians, including, but not limited to, imaging data, clinical utility data, demographics, pathology, treatment, and surveillance.
  • S
    Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients
    The main purpose of this research is to determine whether injecting mesenchymal precursor cells (MPC) into the heart during surgery to implant a left ventricular assist device (LVAD) is safe. MPCs are normally present in human bone marrow and have been shown to increase the development of blood vessels and new heart muscle cells in the heart. In addition, this research is being done to test whether injecting the MPCs into the heart is effective in improving heart function.
  • A
    A Phase 3, Randomized, Placebo-Controlled Study of Lenzilumab in Hospitalized Patients with COVID-19 Pneumonia
    Jul 2020 - Oct 2020 (4 months)
  • A
    A Phase 3, Randomized, Placebo-Controlled Study of Lenzilumab in Hospitalized Patients with COVID-19 Pneumonia
    Jul 2020 - Oct 2020 (4 months)
    To assess whether the use of lenzilumab in addition to current standard of care (SOC) can alleviate the immune-mediated cytokine release syndrome (CRS) and prevent progression to respiratory failure and/or death in high risk patients with COVID-19 pneumonia
  • R
    Retrospective Study of Surgical Complications in Patients with Defunctioning Stoma After Low Anterior Resection for Rect
    May 2020 - Oct 2020 (6 months)
    Co-Coordinator
  • A
    ARISE: Evaluation of the GORE Ascending Stent Graft in the Treatment of DeBakey Type I/II Dissection
    Dec 2019 - Oct 2020 (11 months)
    Primary Research Coordinator
  • T
    Target-CR0002-Ablative
    Sep 2019 - Oct 2020 (1 year 2 months)
    Primary Research Coordinator - Unmasked
  • E
    Epifix Vs. Control in the Treatment of Partial Thickness Burns
    Aug 2019
    To determine the safety and effectiveness of EpiFix® plus Control (Mepilex ® Ag) as compared to Control alone for the treatment of second degree burns as assessed by time to healing and scarring.
  • E
    Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Parare
    Apr 2019 - Oct 2020 (1 year 7 months)
    Primary Research Coordinator
  • R
    RelayPro Thoracic Stent-Graft in Subjects with Acute, Complicated Type B Aortic Dissections
    Nov 2018 - Oct 2020 (2 years)
    Back up Research Coordinator
  • R
    RelayPro Thoracic Stent-Graft in Subjects with Traumatic Injury of the Descending Thoracic Aorta
    Nov 2018 - Oct 2020 (2 years)
    Primary Research Coordinator
  • E
    Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch
    Aug 2017 - Oct 2020 (3 years 3 months)
    Primary Research Coordinator
  • T
    The RE-ENERGIZE Study: RandomizEd Trial of ENtERal Glutamine to minimIZE Thermal Injury (RE-ENERGIZE)
    Aug 2016 - Oct 2020 (4 years 3 months)
    Back up Coordinator
  • C
    CALIBER-Randomized Controlled Trial of LINX versus Double-Dose Proton Pump Inhibitor Therapy for Reflex Disease
    Jul 2015
    This study compares mechanical sphincter augmentation (LINX Reflux Management System) to double-dose proton pump inhibitors (PPIs) for the management of reflux symptoms related to gastroesophageal reflux disease (GERD).
  • C
    CREST-2 Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis
    May 2015 - Oct 2020 (5 years 6 months)
    Primary Research Coordinator
  • A
    Atricure Synergy Ablation Lesions for Non-Paroxysmal Forms of Atrial Fibrillation Treatment During Concomitant On-Pump E
    Oct 2014 - Jan 2018 (3 years 4 months)
    The primary objective of this post-approval study is to evaluate the clinical outcomes in a cohort of patients with non-paroxysmal forms of atrial fibrillation (persistent or long-standing persistent) treated during commercial use of the AtriCure Synergy Ablation System by physicians performed the Maze IV procedure.
Publications verified_user 0% verified
  • T
    Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery
    The New England Journal of Medicine Apr
    ●Listed under supplementary appendix for CTSN
  • R
    RTVue Fourier-Domain Optical Coherence Tomography Primer Series-Vol.II Cornea and Anterior Segment.
    Contributing Authors: P Binder, MD, S Trokel, MD, C Salaroli, MD; Y Li; PhD, S Yiu, MD, PhD; S Ramos, COA; D Huang MD, PhD.
  • A
    Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid
    Aug
    Friedman DS, Holbrook JT, Ansari H, Alexander J, Burke A, Reed SB, Katz J, Thorne JE, Lightman SL, Kempen JH; MUST Research Group. Ophthalmology. 2013 Aug;120(8):1571-9. doi: 10.1016/j.ophtha.2013.01.025. Epub 2013 Apr 16.
  • NOV
    Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relatio
    NOV
    OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group, Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith MJ, Sibony P, Plumb K, Wang JK, Werner JS.
    Invest Ophthalmol Vis Sci. 2014 Nov 4;55(12):8173-9. doi: 10.1167/iovs.14-14961.
  • O
    Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior,
    OCT
    Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Sugar EA, Holbrook JT, Kempen JH, Burke AE, Drye LT, Thorne JE, Louis TA, Jabs DA, Altaweel MM, Frick KD.
    Ophthalmology. 2014 Oct;121(10):1855-62. doi: 10.1016/j.ophtha.2014.04.022. Epub 2014 Jun 5.
  • Sep
    Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema
    Sep
    Kempen JH, Sugar EA, Jaffe GJ, Acharya NR, Dunn JP, Elner SG, Lightman SL, Thorne JE, Vitale AT, Altaweel MM;Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group
  • NOV
    Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparis
    NOV
    OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group, Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith M, Sibony P, Plumb K, Wang JK, Werner JS.
    Invest Ophthalmol Vis Sci. 2014 Nov 4;55(12):8180-8. doi: 10.1167/iovs.14-14960. Erratum in: Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6909
  • A
    Morphologic assessment for glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial
    Aug
    Gangaputra SS, Altaweel MM, Peng Q, Friedman DS, Rao PK, Foster CS, Kim RY, Reed SB, Srivastava SK, Wong IG, Kempen JH; MUST Trial Research Group
  • A
    Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial
    Apr
    Sen HN, Drye LT, Goldstein DA, Larson TA, Merrill PT, Pavan PR, Sheppard JD, Burke A, Srivastava SK, Jabs DA; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Ocul Immunol Inflamm. 2012 Apr;20(2):104-12. doi: 10.3109/09273948.2011.647228.
  • J
    Mapping of macular substructures with optical coherence tomography for glaucoma
    Jan
    Tan 0, Li G, Lu ATH, Varma R, Huang D; Advanced Imaging for Glaucoma Study
    Group
  • J
    Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2
    Jul
    Danis RP, Domalpally A, Chew EY, Clemons TE, Armstrong J, SanGiovanni JP, Ferris FL 3rd; AREDS2 Study Group. Invest Ophthalmol Vis Sci. 2013 Jul 8;54(7):4548-54. doi: 10.1167/iovs.13-11804.
  • J
    The idiopathic intracranial hypertension treatment trial: clinical profile at baseline
    Jun
    Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP; NORDIC Idiopathic Intracranial Hypertension Study Group.
    JAMA Neurol. 2014 Jun;71(6):693-701. doi: 10.1001/jamaneurol.2014.133.
  • O
    Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveiti
    OCT
    Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, Drye LT, Holbrook JT, Jabs DA, Sugar EA, Thorne JE.
    Ophthalmology. 2015 Oct;122(10):1967-75. doi: 10.1016/j.ophtha.2015.06.042. Epub 2015 Aug 20.
  • C
    Correlation Between Optical Coherence Tomography-Derived Assessments of Lower Tear Meniscus Parameters and Clinical Feat
    Cornea Jun
    Pho Nguyen, MD,● David Huang, MD, PhD,●† Yan Li, PhD,●† Srinivas R. Sadda, MD,●
    Sylvia Ramos,● Rajeev R. Pappuru, MD,● and Samuel C. Yiu, PhD, MD●
  • J
    Rapid Adaptation of a Surgical Research Unit to Conduct Clinical Trials during the Coronavirus-19 Pandemic
    Journal of Surgical Research May
    Acknowledgment for contributions to the Division of Clinical Research
  • Sep
    Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension
    Sep
    Wall M, Falardeau J, Fletcher WA, Granadier RJ, Lam BL, Longmuir RA, Patel AD, Bruce BB, He H, McDermott MP; NORDIC Idiopathic Intracranial Hypertension Study Group.
    Neurology. 2015 Sep 1;85(9):799-805. doi: 10.1212/WNL.0000000000001896. Epub 2015 Aug 5
This is a community-created genome.